Morinaga&Co (2201) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Oct, 2026Executive summary
9M net sales rose 7.8% YoY to ¥176,584m; operating income fell 1.3% to ¥19,427m and parent-attributable profit fell 2.7% to ¥13,601m.
Sales growth was led by Confectionery & Foodstuffs and Frozen Desserts; higher raw-material costs, particularly cacao, pressured profitability.
The 2024 Medium-Term Business Plan focuses on strengthening businesses, growth potential and capital efficiency toward the 2030 Business Plan.
Financial highlights
Gross profit rose 4.4% to ¥70,876m; gross margin fell 1.4 points to 40.1%, while SG&A rose 6.7% to ¥51,448m.
Ordinary income declined 1.6% to ¥19,844m; net income was ¥13,717m, down 3.2%, and comprehensive income fell 23.6% to ¥12,654m.
Domestic sales rose 7.0% to ¥152,781m and overseas sales rose 13.5% to ¥23,802m; overseas sales were 13.5% of consolidated sales, up from 12.8%.
Sales growth and price revisions added ¥3.00bn and ¥2.35bn to the operating-income bridge; raw materials, energy and forex reduced it by ¥5.22bn.
EBITDA, defined as operating income plus depreciation and amortization, was ¥26.6bn, down ¥0.1bn YoY.
Outlook and guidance
FY2025 forecasts remain unchanged: net sales ¥227,000m (+6.4%), operating income ¥21,300m (+5.1%), ordinary income ¥21,700m (+3.1%) and parent-attributable profit ¥16,700m (+10.2%).
Full-year operating-income bridge includes a ¥7.36bn headwind from raw materials, energy and forex, offset by ¥3.61bn from sales growth and ¥3.35bn from price revisions.
The full-year dividend forecast remains ¥60 per share; February–March 2025 price increases cover confectionery, selected biscuits and snacks, Chocoball and “in-” protein powders.
Higher sales, price revisions and Group-company contributions are expected to offset greater-than-previously-forecast raw-material impacts; results remain exposed to input costs and exchange rates.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record 9M sales and higher margins lifted full-year forecasts and the dividend.2201
Q3 2024 - Record FY2023 sales and profit growth, with FY2024 growth forecast amid cost headwinds.2201
Q4 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - Record H1 sales and higher FY2025 guidance despite cost-pressured operating income.2201
Q2 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - H1 operating income fell 3.7%, but FY2026 operating-income guidance rose to ¥22.3bn.2201
Q2 2026 - Core sweets growth and MyMo expansion offset by near-term acquisition costs.2201
Q4 2026